BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2022 8:46:13 AM | Browse: 429 | Download: 1645
 |
Received |
|
2021-08-19 07:13 |
|
Peer-Review Started |
|
2021-08-19 07:16 |
|
First Decision by Editorial Office Director |
|
2021-11-11 07:11 |
|
Return for Revision |
|
2021-11-11 07:11 |
|
Revised |
|
2021-11-26 01:57 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-03-18 06:12 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-03-26 22:00 |
|
Articles in Press |
|
2022-03-26 22:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-19 09:11 |
|
Publish the Manuscript Online |
|
2022-05-13 08:46 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Integrative & Complementary Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Hematopoiesis reconstitution and anti-tumor effectiveness of Pai-Neng-Da capsule in acute leukemia patients with haploidentical hematopoietic stem cell transplantation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jiao-Jiao Yuan, Ying Lu, Jun-Jie Cao, Ren-Zhi Pei and Rui-Lan Gao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Zhejiang Provincial Science and Technology Program of Traditional Chinese Medicine |
2018ZA112 |
| the Zhejiang Provincial Science and Technology Program of Traditional Chinese Medicine |
2017ZA129 |
|
| Corresponding Author |
Rui-Lan Gao, PhD, Professor, Institute of Hematology Research, The First Affiliated Hospital of Zhejiang Chinese Medical University, No. 54, Youdian Road, Hangzhou 310006, Zhejiang Province, China. gaorl2021@163.com |
| Key Words |
Pai-Neng-Da Capsule; Hematopoiesis reconstitution; Anti-tumor; Acute leukemia; Haploidentical hematopoietic stem cell transplantation; Effectiveness |
| Core Tip |
New Chinese patent medicine Pai-Neng-Da (PND) Capsule exerts dual effect of promoting hematopoiesis recovery and regulating immunity. However, the efficacy of PND Capsule in patients with haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has not yet been reported. To the best of our knowledge, this is the first study that evaluated the effectiveness of PND Capsule in acute leukemia (AL) patients following haplo-HSCT. Our study showed that PND Capsule could promote hematopoietic function recovery, improve the therapeutic efficacy according to Chinese medical symptom scores, present anti-tumor effectiveness, and prolong the survival of AL patients who underwent haplo-HSCT. |
| Publish Date |
2022-05-13 08:46 |
| Citation |
Yuan JJ, Lu Y, Cao JJ, Pei RZ, Gao RL. Hematopoiesis reconstitution and anti-tumor effectiveness of Pai-Neng-Da capsule in acute leukemia patients with haploidentical hematopoietic stem cell transplantation. World J Clin Cases 2022; 10(14): 4425-4435 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i14/4425.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i14.4425 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
